PH · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $19.85B | $19.93B | $19.07B | $15.86B | $14.35B | $13.70B | $14.32B | $14.30B |
| Cost of Revenue | $12.54B | $12.80B | $12.64B | $10.55B | $9.60B | $10.29B | $10.69B | $10.74B |
| Research & Development | $240.00M | $253.00M | $258.00M | $191.00M | $205.00M | $237.00M | $294.85M | $327.88M |
| Selling, General & Administrative | $3.25B | $3.31B | $3.35B | $2.50B | $2.38B | $1.66B | $1.54B | $1.64B |
| Operating Income | $4.35B | $4.07B | $3.40B | $2.98B | $2.46B | $1.97B | $2.24B | $2.04B |
| Interest Expense | — | — | $573.89M | $255.25M | $250.04M | $308.16M | $190.14M | $213.87M |
| Other Income / (Expense) | $169.00M | $32.00M | -$150.00M | -$1.11B | $37.05M | -$151.69M | -$96.63M | -$122.13M |
| Income Before Taxes | $4.11B | $3.60B | $2.68B | $1.61B | $2.25B | $1.51B | $1.95B | $1.70B |
| Provision for Income Taxes | $575.00M | $750.00M | $596.00M | $298.04M | $500.10M | $304.52M | $424.39M | $640.96M |
| Net Income | $3.53B | $2.84B | $2.08B | $1.32B | $1.75B | $1.20B | $1.52B | $1.06B |
| Basic EPS | $27.52 | $22.13 | $16.23 | $10.24 | $13.54 | $9.36 | $11.73 | $7.98 |
| Diluted EPS | $27.12 | $21.84 | $16.04 | $10.09 | $13.35 | $9.26 | $11.57 | $7.83 |
| Basic Shares Outstanding | 128.30M | 128.50M | 128.40M | 128.54M | 129.00M | 128.42M | 130.00M | 133.00M |
| Diluted Shares Outstanding | 130.20M | 130.20M | 129.90M | 130.36M | 130.83M | 129.81M | 131.78M | 135.43M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jun 2026 | $31.26 | $30.74 | $31.50 | 10 | ↑1 ↓0 |
| Jun 2027 | $34.00 | $33.50 | $34.56 | 11 | ↑1 ↓2 |
| Jun 2028 | $37.62 | $36.76 | $39.05 | 5 | ↑1 ↓0 |
| Jun 2029 | $40.90 | $40.68 | $41.12 | 2 | ↑0 ↓0 |